Synonyms: BIIB-143 | BIIB143 | compound 13b [PMID: 22702513] | compound 3 [PMID: 35905686] | KU-596 | KU596 | RTA 901 | RTA-901
Compound class:
Synthetic organic
Comment: Cemdomespib (BIIB143) is an orally bioavailable small molecule modulator of heat shock (molecular chaperone) proteins with neuroprotective activity [4,6]. It contains the same noviose sugar as the antibacterial compound and heat shock protein 90 (Hsp90) C-terminal inhibitor novobiocin, making it a member of the chemical class termed "novologues" or "noviomimetics" [1]. Hsp90 molecular chaperones are regarded as targets for cancer, neurodegenerative diseases and peripheral neuropathies [7]. Inhibition of Hsp90 by novologues increases expression of Hsp70 [2-3,5]. It is this latter mechanism that is proposed to be of therapeutic benefit in treating diabetic peripheral neuropathy.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[2-[4-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyloxan-2-yl]oxy-2-(3-fluorophenyl)phenyl]ethyl]acetamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
12042 | cemdomespib |
Synonyms ![]() |
BIIB-143 | BIIB143 | compound 13b [PMID: 22702513] | compound 3 [PMID: 35905686] | KU-596 | KU596 | RTA 901 | RTA-901 |
Database Links ![]() |
|
CAS Registry No. | 1450642-92-8 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL2159227 |
DrugBank Ligand | DB18953 |
GtoPdb PubChem SID | 507750360 |
PubChem CID | 60148493 |
Search Google for chemical match using the InChIKey | PDBWOHBMJQOBHL-WBADGQHESA-N |
Search Google for chemicals with the same backbone | PDBWOHBMJQOBHL |
Search PubMed clinical trials | cemdomespib |
Search PubMed titles | cemdomespib |
Search PubMed titles/abstracts | cemdomespib |
UniChem Compound Search for chemical match using the InChIKey | PDBWOHBMJQOBHL-WBADGQHESA-N |
UniChem Connectivity Search for chemical match using the InChIKey | PDBWOHBMJQOBHL-WBADGQHESA-N |